The authors provide actionable steps that researchers and the biomedical community can take to promote more inclusivity in preclinical and basic science research.
Read More
Developing technology ushers in a new era in precision oncology.
Read More
The FDA has approved two comprehensive genomic profiling liquid biopsy tests for use in supporting doctors with their treatment decision-making.
Read More
Decipher’s comprehensive portfolio of tests in urologic cancers leverage whole transcriptome analysis and proprietary machine learning algorithms to improve patient decision-making.
Read More
The strategic partnership between Myriad and Illumina consists of a time-limited exclusive agreement for Illumina to provide a kit-based version of the myChoice CDx test for international markets.
Read More